Skip to content

The evaluation of adjunctive beta-irradiation for trabeculectomy in South Africa: does it enhance operative success and reduce overall failure in glaucoma management?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN62430622
Enrollment
320
Registered
2005-07-22
Start date
1999-11-03
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma Surgery Trabeculectomy

Interventions

African patients with established primary open angle glaucoma requiring trabeculectomy are recruited in three participating centres in South Africa. Following randomisation, patients undergo primary t

Sponsors

University College London (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Consent to inclusion and participation in trial 2. Characteristic glaucomatous changes in the optic disc 3. The presence of a focal or diffuse area of optic disc rim loss, so that the neuroretinal rim tissue in any quadrant is less than 5% of the disc diameter in that meridian 4. Extensive loss of neuroretinal rim tissue with marked optic disc cupping giving a cup disc ratio greater than 0.8 5. A measured intraocular pressure greater than or equal to 21 mmHg on at least one visit before the time of listing for surgery as measured by Goldmann applanation tonometry 6. An open angle on gonioscopy

Exclusion criteria

Exclusion criteria: 1. Unwillingness to participate in the study 2. Anterior segment neovascularisation 3. Past trauma to the eye or ocular adnexae 4. Retinal or optic nerve neovascularisation 5. Aphakia or pseudophakia 6. Previous ocular surgery 7. Uveitis 8. Inability/unwillingness to give informed consent 9. Unwillingness to accept randomisation 10. Patient less than 20 years of age 11. Pregnancy or female of childbearing age who may be pregnant at time of treatment (LMP) 12. Clinically significant cataract 13. Chronic use of topical or systemic steroids

Design outcomes

Primary

MeasureTime frame
Intraocular pressure at 12 months.

Secondary

MeasureTime frame
1. Visual assessment 2. Re-intervention rate 3. Surgical complications

Countries

South Africa

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 8, 2026